News
Hemostatic powder noninferior in nonvariceal upper GI bleeds
December 6, 2021
TC-325 hemostatic powder compares well with standard endoscopic treatment of acute nonvariceal gastrointestinal bleeding in a new study.
![1]()
News
Antibiotics vs. placebo in acute uncomplicated diverticulitis
December 3, 2021
Does antibiotic therapy decrease length of hospital stay for patients with acute uncomplicated diverticulitis?
![1]()
News
Tranexamic acid does not reduce risk of death in GI bleed
December 2, 2021
In patients with GI bleeding, does high-dose tranexamic acid (TXA) reduce the risk of death?
![1]()
News
Oakland score identifies patients with lower GI bleed at low risk for adverse events
November 23, 2021
Is the Oakland score a valid tool to assess the risk of adverse outcomes in adult patients with acute lower GI bleed (LGIB)?
![1]()
News
Is ERCP indicated in gallstone pancreatitis without cholangitis?
November 22, 2021
How necessary is endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy in acute gallstone pancreatitis?
![1]()
News
Timing of endoscopy for acute upper GI bleeding
November 18, 2021
In high-risk patients hospitalized with upper GI bleeding, is earlier endoscopy beneficial?
News
Surgery needed in nearly half of appendicitis patients treated with antibiotics
October 26, 2021
“Substantial numbers of patients report a preference for antibiotics, even if appendectomy may ultimately be necessary.”
News
A pill for C. difficile works by increasing microbiome diversity
October 25, 2021
“I think this marks a moment in this space where we’re going to have better, safer, and more available options for patients.”
News
When can uncomplicated acute appendicitis in adults be treated nonoperatively?
October 18, 2021
Appendiceal diameter greater than or equal to 15 mm on CT and a body temperature of more than 38 °C on admission were associated with primary nonresponsiveness to antibiotic therapy.
News
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
October 11, 2021
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
